A detailed history of Cubist Systematic Strategies, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 67,766 shares of MEDP stock, worth $27.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
67,766
Previous 50,035 35.44%
Holding current value
$27.3 Million
Previous $15.3 Million 78.57%
% of portfolio
0.16%
Previous 0.1%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $5.05 Million - $7.33 Million
17,731 Added 35.44%
67,766 $27.4 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $564,932 - $776,384
-2,483 Reduced 4.73%
50,035 $15.3 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $14.5 Million - $17.5 Million
-62,084 Reduced 54.17%
52,518 $12.7 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $4.21 Million - $5.4 Million
22,502 Added 24.43%
114,602 $27.5 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $457,215 - $628,260
2,623 Added 2.93%
92,100 $17.3 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $8.31 Million - $12.3 Million
54,271 Added 154.15%
89,477 $19 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $1.84 Million - $2.31 Million
-12,676 Reduced 26.47%
35,206 $5.53 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $4.32 Million - $5.57 Million
33,171 Added 225.48%
47,882 $7.17 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $1.07 Million - $1.65 Million
-7,682 Reduced 34.31%
14,711 $2.41 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $1.25 Million - $1.55 Million
6,813 Added 43.73%
22,393 $4.87 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $2,042 - $2,378
-12 Reduced 0.08%
15,580 $2.95 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $283,929 - $347,797
1,790 Added 12.97%
15,592 $2.75 Million
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $224,566 - $286,210
1,701 Added 14.06%
13,802 $2.26 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $2.53 Million - $3.45 Million
-23,136 Reduced 65.66%
12,101 $1.68 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $2.05 Million - $2.88 Million
22,034 Added 166.89%
35,237 $3.94 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $361,981 - $508,730
5,317 Added 67.42%
13,203 $1.23 Million
Q1 2020

May 15, 2020

SELL
$61.71 - $101.95 $58,933 - $97,362
-955 Reduced 10.8%
7,886 $579,000
Q4 2019

Feb 14, 2020

SELL
$70.08 - $84.64 $417,536 - $504,285
-5,958 Reduced 40.26%
8,841 $743,000
Q3 2019

Nov 14, 2019

BUY
$62.38 - $85.89 $923,161 - $1.27 Million
14,799 New
14,799 $1.24 Million
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $193,694 - $236,231
-3,611 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $178,311 - $254,864
3,611 New
3,611 $213,000
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $505,397 - $688,424
-10,760 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $236,101 - $347,956
5,459 Added 102.98%
10,760 $645,000
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $180,393 - $240,983
5,301 New
5,301 $228,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.